DCT Components Improve Trial Access in Underrepresented Communities
New data from the Tufts Center for the Study of Drug Development (CSDD) reveals a correlation between decentralized clinical...
New data from the Tufts Center for the Study of Drug Development (CSDD) reveals a correlation between decentralized clinical...
Introduction The COVID-19 pandemic has significantly disrupted traditional clinical research practices, accelerating the shift towards Decentralized Clinical Trials (DCTs)....
In the rapidly evolving field of clinical trials, Artificial Intelligence (AI) and digital technologies play increasingly crucial roles in...
The clinical trial industry faces a critical juncture as the dust settles from the COVID-19 pandemic. During the height...
In a pivotal webcast hosted by Medable, a panel of distinguished experts, including Pamela Tenaerts (Chief Scientific Officer at...
The FDA’s latest guidance on Decentralized Clinical Trials (DCTs) marks a pivotal shift in the clinical research landscape. This...
The Vanguard of Decentralized Clinical Trials: Bayer’s OCEANIC Study The Medidata NEXT conference spotlighted the groundbreaking OCEANIC study by...
In today’s discussion, we’re joined by Craig Lipset, Co-Chair of the Decentralized Trials & Research Alliance (DTRA), who shares...
This interview features the innovative world of decentralized clinical trials (DCTs) with insights from Darcy Forman of Science 37....
At the inaugural Black Women in Clinical Research conference, Dr. Jayne Morgan, an acclaimed cardiologist and health educator, delivered...